Rating Change
HC Wainwright & Co. analysts reiterated a Buy rating on Alpha Tau Medical Ltd. (NASDAQ:DRTS) on July 16, 2026.
reiterateNASDAQ:DRTS
HC Wainwright & Co. Reiterates Buy Rating on Alpha Tau Medical Ltd. (DRTS)
Rating Change HC Wainwright & Co. analysts reiterated a Buy rating on Alpha Tau Medical Ltd. (NASDAQ:DRTS) on July 16, 2026.
Market Context
Alpha Tau Medical Ltd. operates in the Healthcare sector. The stock currently trades at $12.17 with a market capitalization of $418.2M.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Alpha Tau Medical Ltd..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Alpha Tau Medical Ltd.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 16, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jun 04, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jun 04, 2026 | Barclays | Overweight | N/A |
| Jun 02, 2026 | HC Wainwright & Co. | Buy | N/A |
| May 28, 2026 | Barclays | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View DRTS Stock Page
Frequently Asked Questions
What does a Buy rating mean for DRTS?
A Buy rating from HC Wainwright & Co. reflects the analyst's outlook on Alpha Tau Medical Ltd. (NASDAQ:DRTS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the DRTS forecast page.